Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer

NCT01561443 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01561443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01561443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
January 31, 2015
Enrollment
153 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

local advanced or metastatic postmenopausal breast cancer